+++
title = "FDA authorizes Pfizer Covid booster dose for kids ages 5 to 11 years old"
description = "The FDA determined that a third shot can help boost protection for children in this age group and the benefits outweigh the risks."
date = "2022-05-18 08:17:39"
slug = "6284ab81bdb402c784425edc"
image = "https://i.imgur.com/HFJUUpg.jpg"
score = "1202"
categories = ['children', '11', 'old']
+++

The FDA determined that a third shot can help boost protection for children in this age group and the benefits outweigh the risks.

## Highlights

- Pfizer's Covid vaccine for children ages 5 to 11 at least five months after their two-dose primary series.
- CDC has final say on whether health-care providers should start administering the boosters.
- The FDA determined that a third shot can help boost protection for children in this age group and the benefits outweigh the risks, the FDA says.
- The drug regulator did not identify any new safety concerns and found the children experienced the same mild side effects that other people do after receiving a booster dose.
- The U.S.
- reported more than 90,000 new infections a day on average as of Sunday, a 30% increase over the week prior.

---

{{< rawhtml >}}
  <p class="article-category">
    <a target="_blank" href="https://www.cnbc.com/2022/05/17/fda-authorizes-pfizer-covid-booster-dose-for-kids-ages-5-to-11-years-old.html">READ THE ORIGINAL ARTICLE</a>
  </p>
{{< /rawhtml >}}
